Safety and Tolerability Study for T-1101 (Tosylate) Capsules to Treat Advanced Refractory Solid Tumors

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 7, 2021

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2026

Conditions

Advanced Refractory Solid Tumors

Interventions

DRUG

T-1101 (Tosylate)

T-1101 (Tosylate) Capsule

Trial Locations (2)

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

National Cheng Kung University Hospital, Tainan City

All Listed Sponsors

lead

Taivex Therapeutics Corporation

INDUSTRY